Affiliation:
1. Stavropol State Medical University
2. Stavropol State Medical University;
Filippskiy City Children’s Clinical Hospital;
SOGAZ International Medical Center
3. Russian Medical Academy of Continuous Professional Education
4. Stavropol State Medical University;
Filippskiy City Children’s Clinical Hospital
5. Stavropol State Medical University;
Regional Children’s Clinical Hospital
Abstract
This review presents information on the prevalence, pathogenesis, clinical manifestations, diagnosis and treatment of Duhring’s dermatitis herpetiformis. Although the disease was first clinically described in 1884 by the American dermatologist L.A. Duhring, the study of its pathogenesis and the search for prognostic markers of its occurrence continue. Against the background of a significant expansion of ideas about gluten-dependent diseases and conditions, views on the mechanisms of autoimmune skin damage in dermatitis herpetiformis are detailed. A strong association with hereditary predisposition through the major human leukocyte histocompatibility complex (HLA) DQ2 and DQ8, and a role of epidermal transglutaminase as a major autoantigen in dermatitis herpetiformis are shown. The hypotheses explaining the decline in the incidence of dermatitis herpetiformis in recent decades against the background of increased and more effective serological screening and the resulting earlier diagnosis of celiac disease are commented on. A typical clinical picture of dermatitis herpetiformis, in which erythematous papules, plaques, vesicles are seen, usually clustered on the flexural surfaces of the extremities. Secondary elements are erosions, excoriations and crusts due to rupture of blisters and due to scratching caused by intense itching. A generally favourable prognosis for life and disease is shown with a gluten-free diet and the use of dapsone, glucocorticoids and, if these are ineffective, immunosuppressants. The authors describe a clinical case of the disease in an adolescent girl with a typical clinical history and characteristic rashes on the extensor surfaces of the limbs. The authors show that drug therapy without a gluten-free diet cannot be considered effective, and that the diet for dermatitis herpetiformis, like that for celiac disease, is lifelong. The growing understanding of gluten-associated pathology, which includes dermatitis herpetiformis, in recent decades has led to an intensive search for diagnostic and prognostic markers, as well as the development of ways to correct this group of diseases, including those not related to the lifelong elimination of cereal prolamines.
Reference60 articles.
1. Karyakina L.A., Kukushkina K.S. Skin markers of celiac disease. Medicine: Theory and Practice. 2019;4(1):114–119. (In Russ.) Available at: http://ojs3.gpmu.org/index.php/med-theory-and-practice/article/view/454/456.
2. Novikov Yu.A., Zaslavskiy D.V., Pravdina O.V., Zykova E.A., Lipatnikova A.S., Bolshakova E.S. et al. During’s herpetiform dermatitis in pediatric dermatology: issues of diagnostics and treatment. Pediatrician (St Petersburg). 2020;11(6):79–86. (In Russ.) https://doi.org/10.17816/PED11679-86.
3. Butov Yu.S., Skripkin Yu.K., Ivanov O.L. (eds.). Clinical dermatovenerology: national guidelines. Moscow: GEOTAR-Media; 2013. 896 p. (In Russ.) Available at: http://library.zsmu.edu.ua/cgi/irbis64r_14/fulltext/Dermatovenerologija/ButovJuS13_Dermat_Nacio_ruk.pdf.
4. Antiga E., Maglie R., Quintarelli L., Verdelli A., Bonciani D., Bonciolini V., Caproni M. Dermatitis Herpetiformis: Novel Perspectives. Front Immunol. 2019;10:1290. https://doi.org/10.3389/fimmu.2019.01290.
5. Bolotin D., Petronic-Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011;64(6):1017–1024. https://doi.org/10.1016/j.jaad.2010.09.777.